Clinical Trial Update: Cromolyn Sodium for Treatment of COVID-19 Pneumonia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating cromolyn sodium for COVID-19 pneumonia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia Viral

Drugs mentioned

• Cromolyn Sodium (Cromolyn Sodium)

Snippet

Sponsor: Texas Tech University Health Sciences Center, El Paso | Conditions: COVID-19 Pneumonia, COVID-19 Respiratory Infection | Phase 3 | Status: TERMINATED